Review Paper on Lung Cancer

Abstract

To analyze data available on early lung cancer diagnosis with an emphasis on three technologies: chest x-ray (CXR), low-dose CT screening (LDCT). Plan, place, participants: Early detection technology analysis of the clinical trials released. Each subject was analyzed using the best data available. Randomized experiments have used CXR and cytology sputum measurement. Cohort experiments and studies that have proof. The assessment considered rates of over diagnosis and success of initial treatment LDCT. The nature of the analysis and findings were presented in tables of evidence. Analysis of statistics not done was the integrated data. The early diagnosis of lung cancer uses CXR or sputum cytology. The written proof did not help it. In this regard, the evidence for LDCT is promising technology usually detects early-stage lung cancer, although corollary evidence shows that this can be deceptive observations in isolation. Further study of high quality is important to define clearer the role of LDCT in evaluating high-risk asymptomatic persons.